Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Desmoid Tumors 4Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1HIV Infections 1Granulosa cell tumor of the ovary 1Breast Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

Paclitaxel 2nirogacestat 1halofuginone 1etoposide phosphate 1Thalidomide 1Sunitinib 1Semaxinib 1Saquinavir 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Nelfinavir 1Interleukin-12 Subunit p35 1Indinavir 1Imatinib Mesylate 1Ifosfamide 1Filgrastim 1Etoposide 1Cidofovir 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × AIDS-related Kaposi sarcoma × nirogacestat × Clear all
NCT02137564 2015-07-23

Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡